Activity of CK2α protein kinase is required for efficient replication of some HPV types

Area of Science:

• Virology
• Molecular Biology
• Drug Discovery

Background:

• Human papillomavirus (HPV) replication is essential for HPV-related pathologies.
• Viral proteins E1 and E2 are critical for HPV replication and are phosphoproteins.
• Protein kinases phosphorylating E1 and E2 are potential secondary therapeutic targets.

Purpose of the Study:

• To investigate the role of casein kinase 2 (CK2) in HPV replication.
• To evaluate the efficacy of the CK2 inhibitor CX4945 against different HPV types.
• To determine the specific CK2 subunit involved in regulating HPV replication.

Main Methods:

• Treatment with CX4945, a small molecule inhibitor of CK2.
• Replication assays using novel HPV marker genomes (HPV5NLuc, HPV11NLuc, HPV18NLuc).
• Short interfering RNA (siRNA)-mediated knockdown of CK2 α and α' subunits in U2OS and CIN612 cells.

Main Results:

• CX4945 suppressed replication of HPV5NLuc, HPV11NLuc, and HPV18NLuc, but enhanced HPV16 and HPV31 replication.
• CK2α, but not CK2α', was required for HPV replication, as shown by siRNA knockdown.
• CK2α kinase activity regulated the stability and nuclear retention of HPV11 and HPV18 E1 proteins.

Conclusions:

• CK2α plays a crucial role in HPV replication through kinase activity-dependent regulation of the E1 protein.
• Targeting CK2α represents a promising antiviral strategy for HPV infections.
• The differential effect of CX4945 on various HPV types warrants further investigation.